Skip to main content
. 2013 Jun 12;2013:326258. doi: 10.1155/2013/326258

Table 3.

Adverse events.

Adverse event Simvastatin group Control group P
Elevated aspartate aminotransferase 1 (2%) 2 (4%) 0.558
Elevated alanine aminotransferase 1 (2%) 5 (10%) 0.092
Elevated creatine phosphokinase 1 (2%) 2 (4%) 0.558
Myalgia 2 (4%) 3 (6%) 0.646
Muscle weakness 1 (2%) 2 (4%) 0.558
Abdominal pain 4 (8%) 6 (12%) 0.505
Nausea 6 (12%) 4 (8%) 0.505
Constipation 0 (0%) 1 (2%) 0.315
Diarrhea 0 (0%) 1 (2%) 0.315
Flatulence 1 (2%) 2 (4%) 0.558
Asthenia 2 (4%) 4 (8%) 0.400
Dizziness 1 (2%) 3 (6%) 0.307
Headache 2 (4%) 4 (8%) 0.400
Allergy 0 (0%) 1 (2%) 0.315